General Information of Drug (ID: DM1ERXJ)

Drug Name
JNJ-47910382
Indication
Disease Entry ICD 11 Status REF
Hepatitis C virus infection 1E51.1 Phase 1 [1]
Cross-matching ID
TTD ID
D0DA6X

References

1 ClinicalTrials.gov (NCT01482611) A Study in Healthy Participants Investigating the Safety, Tolerability and Plasma Pharmacokinetics (PK) of Single Oral Doses of JNJ-47910382. U.S. National Institutesof Health.